| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 01/26/2005 | EP1499352A1 Recombinant anti-interleukin-9 antibodies |
| 01/26/2005 | EP1499345A2 Protein a compositions and methods of use |
| 01/26/2005 | EP1499320A1 Novel compounds |
| 01/26/2005 | EP1499308A2 Tri-substituted heteroaryls and methods of making and using the same |
| 01/26/2005 | EP1499294A2 Transport system in biological systems |
| 01/26/2005 | EP1301514B1 Aryl and heteroaryl diazabicycloalkanes, their preparation and use |
| 01/26/2005 | EP1296976B1 Novel 1,3-dihydro-2h-indol-one derivatives, method for preparing same and pharmaceutical compositions containing them |
| 01/26/2005 | EP1283047A4 Method for producing a bioactive substance from blood serum |
| 01/26/2005 | EP1084109B1 2-aminopyridines containing fused ring substituents as nitric oxide synthase inhibitors |
| 01/26/2005 | EP0983267B1 Amidoaromatic ring sulfonamide hydroxamic acid compounds |
| 01/26/2005 | EP0866691B2 Sublingual and buccal administration of selegiline |
| 01/26/2005 | CN1571794A Cyclosporine analogue mixtures and their use as immunomodulating agents |
| 01/26/2005 | CN1571781A 4-imidazolin-2-one compounds |
| 01/26/2005 | CN1571770A Aralkyl-tetrahydro-pyridines, their preparation and pharmaceutical compositions containing same |
| 01/26/2005 | CN1569867A Preparation method and use of skunk bush extract morroniside |
| 01/26/2005 | CN1569219A Eye drop for treating amblyopia and its preparing process |
| 01/26/2005 | CN1569120A Effective portion extraction of dogwood and its preparation method and usage |
| 01/26/2005 | CN1569097A Externally used traditional Chinese medicine preparation for treating teenager myopia and its preparing method |
| 01/26/2005 | CN1569068A Preparation method of |
| 01/26/2005 | CN1569051A Medicine for treating congenital deafmutism |
| 01/26/2005 | CN1569027A Powdered eye disease treating medicine |
| 01/26/2005 | CN1186332C New thryoid receptor ligands and process II |
| 01/26/2005 | CN1186097C Pharmaceutical compositions comprising an aldose reductase inhibitor and an ACE inhibitor |
| 01/26/2005 | CN1186040C Sight promoting agent |
| 01/26/2005 | CN1186019C Method for increasing retinal blood flow |
| 01/25/2005 | US6846835 Treating chronic obstructive pulmonary disease, chronic bronchitis, asthma, chronic respiratory tract obstruction, fibroid lung, pulmonary emphysema or rhinitis |
| 01/25/2005 | US6846833 Vitronectin receptor antagonist bicyclic compounds, preparation method and compositions containing same |
| 01/25/2005 | US6846499 Medical effect of jojoba oil |
| 01/20/2005 | WO2005006807A1 Transmitter of wireless microphone, receiver for wireless microphone, mobile information communication apparatus, and communication system for wireless microphone |
| 01/20/2005 | WO2005006806A1 Wireless microphone communication system |
| 01/20/2005 | WO2005004859A1 Coumarin derivatives for the treatment of ophthalmic disorders |
| 01/20/2005 | WO2004083382A3 Compositions and methods for treating hyperimmune response in the eye |
| 01/20/2005 | WO2004069142A3 Anti-candida agents for the treatment of prion diseases |
| 01/20/2005 | WO2003076443A9 Spiro compounds with npy antagonistic activity |
| 01/20/2005 | WO2003072114A8 Vascular therapeutics |
| 01/20/2005 | WO2003062392A3 Methods of treating conditions associated with an edg receptor |
| 01/20/2005 | WO2002050289A8 Methods for the production of multimeric proteins, and related compositions |
| 01/20/2005 | US20050014938 Phenyl substituted triazoles and their use as selective inhibitors of akl5 kinase |
| 01/20/2005 | US20050014846 Oral administration, bioavailability; no central nervous and cardiovascular side effects |
| 01/20/2005 | US20050014841 Branched chain amino acid-dependent aminotransferase inhibitors and their use in the treatment of neurodegenerative diseases |
| 01/20/2005 | US20050014837 Method for treating ocular hypertension and glaucoma |
| 01/20/2005 | US20050014808 Combined agents for treatment of glaucoma |
| 01/20/2005 | US20050014800 Vision defects; anticancer agents; antitumor agents |
| 01/20/2005 | US20050014795 Aralkyl-tetrahydro-pyridines, their preparation and pharmaceutical compositions containing same |
| 01/20/2005 | US20050014788 Piperidine derivatives and their use as modulators of chemokine receptor activity (especially ccr5) |
| 01/20/2005 | US20050014741 2-oxo-benzimidazolyl substituted ethanolamine derivatives and their use as beta3 agonists |
| 01/20/2005 | US20050014705 E.g., dimethylcarbamic acid, 2-oxo-3-benzyl-4-methyl-2H-1-benzopyran; affects both the Tumor Necrosis Factor alpha level and transcription activity of NuclearFactor kappa Beta; antiimmunoinflammatory agents and autoimmune properties; antiarthritis agents; rheummatic diseases; osteoporosis; leukemia |
| 01/20/2005 | US20050014695 Uses of a chemokine receptor able to bind to MCP-1, MIP-1 alpha and/or rantes |
| 01/20/2005 | US20050014693 Transmission and, or amplification of signals; oral or enteric administering, dissolving, absorption of peptide yy; obesity therapy |
| 01/20/2005 | US20050014691 Ophthalmic compositions comprising trefoil factor family peptides |
| 01/20/2005 | US20050014686 Somatostatin analogues |
| 01/20/2005 | US20050014188 Isolated human dehydrogenases, nucleic acid molecules encoding these human dehydrogenases, and uses thereof |
| 01/20/2005 | CA2569537A1 Use of betaine for treating arteritis |
| 01/20/2005 | CA2528148A1 Coumarin derivatives for the treatment of ophthalmic disorders |
| 01/19/2005 | EP1498125A1 Use of compounds having ccr antagonism |
| 01/19/2005 | EP1497420A2 Agents which regulate, inhibit, or modulate the activity and/or expression of connective tissue growth factor (ctgf) as a unique means to both lower intraocular pressure and treat glaucomatous retinopathies/optic neuropathies |
| 01/19/2005 | EP1497401A1 Method for obtaining ozonized oils and vegetable fats and use of said products for pharmaceutical and cosmetic purposes |
| 01/19/2005 | EP1497334A2 Protein stabilisation using chaperone proteins |
| 01/19/2005 | EP1497292A1 Azaindolylpiperidine derivatives as antihistaminic and antiallergic agents |
| 01/19/2005 | EP1497274A2 Terphenyl derivatives, preparation thereof, compositions containing same |
| 01/19/2005 | EP1497273A2 Hydroxamic acid derivatives |
| 01/19/2005 | EP1497261A1 Phenethanolamine derivatives |
| 01/19/2005 | EP1497256A1 Substituted 1,5-diaminopentan-3-ol compounds |
| 01/19/2005 | EP1496912A1 Combination of brimonidine and timolol for topical ophthalmic use |
| 01/19/2005 | EP1496910A1 Kinase inhibitors |
| 01/19/2005 | EP1496907A2 Tyrosine kinase inhibitors |
| 01/19/2005 | EP1496904A1 Pharmaceutical containing n, n'-disubstituted piperazine compounds |
| 01/19/2005 | EP1496900A2 New pharmaceutical compositions based on anticholinergics and p38 kinase inhibitors |
| 01/19/2005 | EP1496898A2 Tyrosine kinase inhibitors |
| 01/19/2005 | EP1496894A1 Angiogenesis inhibitors |
| 01/19/2005 | EP1496893A2 Neuroprotectant methods, compositions, and screening methods thereof |
| 01/19/2005 | EP1496892A2 1h-benzo(f)indazol-5-yl derivatives as selective glucocorticoid receptor modulators |
| 01/19/2005 | EP1496881A2 Chromium compositions and methods for using the same for inhibiting drug-induced insulin resistance |
| 01/19/2005 | EP1496878A1 Methods for identification of modulators of angiogenesis, compounds discovered thereby, and methods of treatment using the compounds |
| 01/19/2005 | EP1265615B1 Novel combination of non-sedative anti-histamines containing substances which influence the action of leukotriene, for treating rhinitis/conjunctivitis |
| 01/19/2005 | CN1568322A Pharmaceutically active sulfonamide derivatives bearing both lipophilic and ionisable moieties as inhibitors of protein junkinases |
| 01/19/2005 | CN1568320A 异羟肟酸衍生物 Hydroxamic acid derivatives |
| 01/19/2005 | CN1568207A 2-amino-6-(2, 4, 5-substituted-phenyl)-pyridines |
| 01/19/2005 | CN1566126A Novel natural drug effective region |
| 01/19/2005 | CN1566096A Prostaglandin agonists and their use to treat bonedisorders |
| 01/19/2005 | CN1565623A Calcitonin composition |
| 01/19/2005 | CN1565583A Chinese drugs compositions for treating diabetes and its complications |
| 01/19/2005 | CN1565501A Novel preparation method of |
| 01/19/2005 | CN1565479A Musk liposome injection and its preparation method |
| 01/19/2005 | CN1565478A Musk medicated thread and its preparation method |
| 01/19/2005 | CN1185250C Compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 01/19/2005 | CN1185233C Aryl and heteroaryl diazabicycloalkanes, their preparation and use |
| 01/19/2005 | CN1185232C Inhibitors of alpha L beta 2 mediated cell adhesion |
| 01/19/2005 | CN1185215C Substituted glutarimides and use as IL-12 production inhibitors thereof |
| 01/19/2005 | CN1185213C Azetidine derivatives, preparation and pharmaceutical compositions thereof |
| 01/19/2005 | CN1185009C Eye preparation |
| 01/19/2005 | CN1184968C Antibiotic compositions for treatment of the eye, ear and nose |
| 01/18/2005 | US6844349 Salt forms of E-2-methoxy-N-(3-{4-[3 methyl-4-(6-methyl-pyridin-3-yloxy)-phenylamino]-quinazolin-6-yl}-allyl)-acetamide and method of production |
| 01/18/2005 | US6844341 Cell cycle kinase inhibitors; such as 2-(4-(N-(2-methoxy-ethyl)-sulphamoyl)anilino)-4-(imidazo(1,2b)pyridazin-3 -yl)-pyrimidine |
| 01/18/2005 | US6844335 2-amino-3-(alkyl)-pyrimidone derivatives as GSK3.β.inhibitors |
| 01/18/2005 | US6844314 Use of copolymer 1 and related peptides and polypeptides and T cells treated therewith for neuroprotective therapy |
| 01/18/2005 | US6843992 Immuno-reactive peptide CTL epitopes of human cytomegalovirus |
| 01/13/2005 | WO2005003111A1 Preventive or remedy for viral conjunctivitis |
| 01/13/2005 | WO2005002595A1 Ophthalmic composition |
| 01/13/2005 | WO2005002520A2 Ophthalmic compositions for treating ocular hypertension |